NCT04514484 2026-03-23
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
Phase 1 Active not recruiting
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
McGill University Health Centre/Research Institute of the McGill University Health Centre
AIDS Malignancy Consortium